pubmed.ncbi.nlm.nih.gov

Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels - PubMed

Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels

Neil A Turner et al. FASEB J. 2005 May.

Abstract

Increased matrix metalloproteinase-9 (MMP-9) expression is associated with intimal hyperplasia in saphenous vein (SV) bypass grafts. Recent evidence suggests that HMG-CoA reductase inhibitors (statins) can prevent the progression of vein graft failure. Here we investigated whether statins inhibited MMP-9 secretion from cultured human SV smooth muscle cells (SMC) and examined the underlying mechanisms. SV-SMC from different patients were exposed to phorbol ester (TPA) or PDGF-BB plus interleukin-1alpha (IL-1). MMP-9 secretion and mRNA expression were analyzed using gelatin zymography and RT-PCR, respectively. Specific signal transduction pathways were investigated by immunoblotting and pharmacological inhibition. Simvastatin reduced TPA- and PDGF/IL-1-induced MMP-9 secretion and mRNA levels, effects reversed by geranylgeranyl pyrophosphate and mimicked by inhibiting Rho geranylgeranylation or Rho-kinase (ROCK). MMP-9 secretion induced by PDGF/IL-1 was mediated via the ERK, p38 MAPK, and NFkappaB pathways, whereas that induced by TPA was mediated specifically via the ERK pathway. Simvastatin failed to inhibit activation of these signaling pathways. Moreover, simvastatin did not affect MMP-9 mRNA stability. Together these data suggest that simvastatin reduces MMP-9 secretion from human SV-SMC by inhibiting the RhoA/ROCK pathway and decreasing MMP-9 mRNA levels independently of effects on signaling pathways required for MMP-9 gene expression.

PubMed Disclaimer

Cited by

Involvement of Rho kinase (ROCK) in sepsis-induced acute lung injury.
Cinel I, Ark M, Dellinger P, Karabacak T, Tamer L, Cinel L, Michael P, Hussein S, Parrillo JE, Kumar A, Kumar A. Cinel I, et al. J Thorac Dis. 2012 Feb;4(1):30-9. doi: 10.3978/j.issn.2072-1439.2010.08.04. J Thorac Dis. 2012. PMID: 22295165 Free PMC article.
Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis.
Paintlia AS, Paintlia MK, Singh I, Singh AK. Paintlia AS, et al. Exp Neurol. 2008 Dec;214(2):168-80. doi: 10.1016/j.expneurol.2008.07.024. Epub 2008 Aug 7. Exp Neurol. 2008. PMID: 18775426 Free PMC article.
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
Fromigué O, Hamidouche Z, Marie PJ. Fromigué O, et al. J Biol Chem. 2008 Nov 7;283(45):30549-56. doi: 10.1074/jbc.M801436200. Epub 2008 Aug 29. J Biol Chem. 2008. PMID: 18757369 Free PMC article.
Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease.
Xu Y, Wang Y, Zhi J, Qi L, Zhang T, Li X. Xu Y, et al. BMC Pharmacol Toxicol. 2017 Apr 8;18(1):28. doi: 10.1186/s40360-017-0132-y. BMC Pharmacol Toxicol. 2017. PMID: 28390432 Free PMC article. Clinical Trial.
The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator.
Babenko VA, Fedulova KS, Silachev DN, Rahimi-Moghaddam P, Kalyuzhnaya YN, Demyanenko SV, Plotnikov EY. Babenko VA, et al. J Pers Med. 2023 Jul 23;13(7):1175. doi: 10.3390/jpm13071175. J Pers Med. 2023. PMID: 37511788 Free PMC article. Review.

Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels - PubMed